Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

Overview of attention for article published in Breast Cancer Research, November 2007

Altmetric Badge

Mentioned by

patent: 2 patents

Readers on

mendeley: 47 Mendeley
citeulike: 4 CiteULike

Summary Patents

So far, Altmetric has seen 2 patents that reference this research output.

Genetic variants on CHR16 as markers for use in breast cancer risk assessment, diagnosis…

Application EP-2540840-A3

European Patent Office

Genetic variants on CHR16 as markers for use in breast cancer risk assessment, diagnosis…

Application EP-2540840-A2

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.